Table 1.

Prevalence of OIs and HIV-associated malignancies disaggregated by clinical characteristics among WLHIV in Ethiopia (2007–2019).

Characteristics	Oral candidiasis (%)	Herpes (%)	PCP (%)	Toxoplasmosis (%)	TB (%)	Overall OIs (%)	Cervical cancer (%)	Lymphoma (%)	Overall malignancies (%)
Residency
Urban	14.3	9.8	2.2	1.4	11.0	38.8	11.9	13.2	25.1
Rural	13.5	7.7	2.7	3.8	14.2	41.9	11.5	14.2	25.7
Age
≤24	16.5	8.7	2.6	1.7	12.1	41.6	13.0	11.3	24.3
25–34	13.1	9.9	2.5	1.6	11.3	38.3	7.7	12.6	20.3
35–44	14.9	9.9	2.1	1.6	10.9	39.4	14.9	12.1	27.0
45–54	16.3	8.6	1.7	1.7	12.1	40.4	12.6	16.3	28.9
55–64	8.4	9.6	3.0	1.2	11.4	33.7	19.3	13.9	33.2
65–74	15.2	10.9	0.0	2.2	6.5	34.8	13.0	13.4	26.4
≥75	33.3	0.0	0.0	0.0	16.7	50.0	16.7	80.0	96.7
Adherence
Poor	7.1	14.3	0.0	0.0	7.1	28.6	10.7	11.7	22.4
Fair	5.0	15.0	0.0	0.0	15.0	35.0	9.1	18.2	27.3
Good	13.0	10.4	2.3	1.3	8.6	35.7	16.7	16.7	33.4
Very good	14.5	9.5	2.3	1.7	11.6	39.5	10.7	16.0	26.7
Functional status
Ambulatory	14.3	9.7	2.3	1.6	11.2	39.0	14.1	11.1	25.2
Bedridden	8.9	6.7	0.0	4.4	17.8	37.8	11.5	13.2	24.7
Clinical stage
I	14.2	9.6	2.2	1.4	11.2	38.7	14.0	14.0	28.0
II	13.9	9.8	2.8	3.2	12.3	42.0	6.6	8.2	14.8
III	18.2	3.0	3.0	3.0	3.0	30.3	14.2	12.3	26.5
IV	16.7	50.0	0.0	16.7	16.7	100.0	11.1	13.0	24.1
Viral load
≤1000	14.2	9.5	2.2	1.5	10.5	37.9	12.6	15.1	27.7
>1000	14.4	11.3	3.4	2.4	20.3	51.9	19.3	14.5	33.8
CD4 count
≤500	16.3	14.2	2.9	3.0	15.7	52.1	13.0	21.7	34.7
>500	13.1	7.1	1.9	0.8	8.7	31.5	16.7	0.0	16.7
Overall (%)	14.2	9.6	2.3	1.6	11.3	39.0	11.9	13.3	25.2